Development of therapeutic anti-JAGGED1 antibodies for cancer therapy

The role of Notch signaling and its ligand JAGGED1 (JAG1) in tumor biology have been firmly established, making them appealing therapeutic targets for cancer treatment. Here we report the development and characterization of human/rat-specific JAG1-neutralizing monoclonal antibodies. Epitope mapping...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Main Authors: Masiero, Massimo, Li, Demin, Whiteman, Pat, Bentley, Carol, Greig, Jenny, Hassanali, Tasneem, Watts, Sarah, Stribbling, Stephen, Yates, Jenna, Bealing, Ellen, Li, Ji-Liang, Chillakuri, Chandramouli, Sheppard, Devon, Serres, Sébastien, Sarmiento-Soto, Manuel, Larkin, James, Sibson, Nicola R., Handford, Penny A., Harris, Adrian L., Banham, Alison H.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611158/
https://ncbi.nlm.nih.gov/pubmed/31395687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1176
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares